Seagen Inc (NASDAQ:SGEN)

212.84
BATS BZX Real-Time Price
As of 1:44pm ET
 -3.16 / -1.46%
Today’s Change
116.08
Today|||52-Week Range
217.08
+65.62%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$40.1B

Company Description

Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA.

Contact Information

Seagen Inc.
21823 30th Drive South East
Bothell Washington 98021
P:(425) 527-4000
Investor Relations:

Employees

Shareholders

Other institutional47.18%
Mutual fund holders39.74%
Individual stakeholders25.06%

Top Executives

David R. EpsteinChief Executive Officer & Director
Todd E. SimpsonChief Financial Officer
Vaughn B. HimesChief Technical Officer
Roger D. DanseyChief Medical Officer & President-Research
Karin A. TollefsonSenior VP & Head-Global Medical Affairs